Recruiting Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy NCT07390071 Conditions Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune Effector Cell Associated Neurotoxicity Syndrome, +14 more Locations Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah, United States View Trial Details
Recruiting Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome NCT06706102 Conditions Immune Effector Cell Associated Neurotoxicity Syndrome Locations CHU de Saint-Etienne — Saint-Etienne, France View Trial Details
Recruiting Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome NCT05643092 Conditions Immune Effector Cell Associated Neurotoxicity Syndrome Locations 980th Hospital — Shijiazhuang, Hebei, China View Trial Details
Not Yet Recruiting Pre-emptive Anakinra for Cytokine Event Reduction NCT06703216 Conditions B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more Locations Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States View Trial Details
Not Yet Recruiting Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812 Conditions Chemically-Induced Disorders, Hematologic Diseases, Hematologic Malignancy, +9 more Locations Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States View Trial Details
